Antireflux Surgery in Korea: A Nationwide Study from 2011 to 2014.
- Author:
Jun Hyun LEE
1
;
Joong Min PARK
;
Sang Uk HAN
;
Jin Jo KIM
;
Kyo Young SONG
;
Seung Wan RYU
;
Kyung Won SEO
;
Hyoung Il KIM
;
Wook KIM
Author Information
- Publication Type:Original Article
- Keywords: Laparoscopic fundoplication; Gastroesophageal reflux disease; Proton pump inhibitors; Nationwide Korean data
- MeSH: Fundoplication; Gastroesophageal Reflux; Humans; Korea*; Length of Stay; Methods; Operative Time; Proton Pump Inhibitors; Proton Pumps
- From:Gut and Liver 2016;10(5):726-730
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND/AIMS: Although laparoscopic fundoplication is a well-established therapy for gastroesophageal reflux disease (GERD) in Western countries, the mainstay of GERD treatment in Korea is long-term proton pump inhibitor (PPI) use. The aim of the present study was to evaluate nationwide data regarding antireflux surgery in Korea. METHODS: Data from 2011 to 2014 were collected from the Korean Antireflux Surgery Study Group and then analyzed. RESULTS: A total of 87 patients underwent laparoscopic fundoplication for the treatment of GERD. Preoperatively, typical symptoms were present in 81 patients (93%) and atypical symptoms were present in 51 patients (59%). Twenty-seven patients (31%) had poor PPI responses. The average surgical time and postoperative hospital stay were 116.3±42.3 minutes and 4.3±3.1 days, respectively. At 3 months after surgery, typical symptoms were completely controlled in 86.3% of patients and partially controlled in 11.7%, whereas atypical symptoms were completely controlled in 63.3% of patients and partially controlled in 23.3%. CONCLUSIONS: This study showed that although atypical symptoms and PPI nonresponders are common, the complete control rates of typical and atypical symptoms were 86.3% and 63.3%, respectively. Laparoscopic fundoplication is an efficacious method of controlling the symptoms of GERD and has an acceptable rate of postoperative morbidity and adverse symptoms.
